Abstract:Background Diabetes mellitus (DM) is a chronic disease characterized by hyperglycemia due to changes in the hormone insulin. The most common type is type 2(DM2), which has insulin resistance as one of its manifestations. Several metabolic changes affect these patients, including endothelial dysfunction and vascular and neurological disorders, as well as impact on quality of life, mental health, and sleep. Pharmacological therapy is one of the main interventions, associated with adaptations in the diet and physical activity routine. However, patients with DM2 do not adhere to treatment for various reasons and the disease continues its progression, burdening the entire health system and impacting the lives of this individual and his entire community. Photobiomodulation therapy (PBMT) appears as an alternative because it acts on energy metabolism, the side effects are negligible, and its non-invasive application can favor adherence. Several scientific studies have shown its effectiveness in glycemic control in an experimental model and the first studies with humans are beginning to emerge to consolidate this possibility. Objectives To verify the effects of PBMT by infrared LED on blood glucose levels and consequent impact on the biopsychosocial context of patients with DM2. Therefore, initial and final laboratory tests of fasting blood glucose, glycated hemoglobin, HOMA-IR index and application of quality of life and sleep questionnaires, perception of pain, sensitivity and mental health will be carried out. Methods Randomized, double-blind controlled trial with sham group. Sample space of 36 volunteers diagnosed with DM2, distributed in: sham (irradiation with zero parameters), panel (irradiation by the Joovv Elite system of the whole body) and blanket (irradiation with a flexible blanket prototype applied to the abdomen and bilaterally to the quadriceps femoris, hamstrings, triceps surae, arm and forearm). The volunteers underwent initial and final assessments consisting of laboratory tests (fasting blood glucose, glycated hemoglobin and HOMA-IR index) and questionnaires (Diabetes Quality of Life-Brazil-8, Neuropathic Pain Questionnaire 4, painDETECT, Sleep Quality Index of Pittsburgh, Depression, Anxiety and Stress Scale). Participants will be irradiated (active or not) every other day within a 12-day period. Results, Conclusion, and Implications As this is a study protocol, there are no results, conclusions, and implications to be presented.

Photobiomodulation Therapy For Burning Mouth Syndrome Management: A Randomized Double-Blind Controlled Trial.

Photobiomodulation Therapy To Treatment Of Burning Mouth Syndrome.

Photobiomodulation alleviates Burning Mouth Syndrome pain: Immediate and weekly outcomes explored

Treatments for Burning Mouth Syndrome: A Network Meta-analysis

Low-level laser therapy in patients with Burning Mouth Syndrome: A double-blind, randomized, controlled clinical trial

Different therapeutic strategies for burning mouth syndrome: preliminary data

Efficacy Evaluation of Clonazepam for Symptom Remission in Burning Mouth Syndrome: a Meta‐analysis

Burning mouth syndrome: current clinical, physiopathologic, and therapeutic data

Photobiomodulation therapy on puncture‐associated pain: A controlled randomized double‐blind clinical trial

Low-level Laser Treatment of Burning Mouth Syndrome: a Systematic Review and Meta-Analysis

Efficacy of cranial electrotherapy stimulation in patients with burning mouth syndrome: a randomized, controlled, double-blind pilot study

The improvement of pain symptoms in patients with burning mouth syndrome through combined laser and medication therapy

Influence of Photobiomodulation Therapy on Gingivitis Induced by Multi-Bracket Appliances: A Split-Mouth Randomized Controlled Trial

Advances in comprehensive multidisciplinary treatment for burning mouth syndrome

Effects of Low-Level Laser Therapy on Burning Pain and Quality of Life in Patients with Burning Mouth Syndrome: a Systematic Review and Meta-Analysis.

Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids

BIOPSYCHOSOCIAL EFFECTS AFTER PHOTOBIOMODULATION FOR GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS

Amitriptyline effectiveness in burning mouth syndrome: An in‐depth case series analysis

50: EFFECT OF LOW-LEVEL LASER THERAPY IN THE TREATMENT OF BURNING MOUTH SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

Effectiveness Of Photbiomodulation Therapy For Oral Mucositis Secondary To Antineoplasic Therapy: An Overview.

Photobiomodulation Therapy In The Control Of Radio-Induced Oral Mucositis: Observational Retrospective Case-Control Study.